147 related articles for article (PubMed ID: 15133030)
1. Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions.
Wei M; Tai G; Gao Y; Li N; Huang B; Zhou Y; Hao S; Zeng X
J Biol Chem; 2004 Jul; 279(28):29202-10. PubMed ID: 15133030
[TBL] [Abstract][Full Text] [Related]
2. Chemically modified heparin inhibits in vitro L-selectin-mediated human ovarian carcinoma cell adhesion.
Chen Z; Jing Y; Song B; Han Y; Chu Y
Int J Gynecol Cancer; 2009 May; 19(4):540-6. PubMed ID: 19509548
[TBL] [Abstract][Full Text] [Related]
3. Chemically modified heparin inhibits the in vitro adhesion of nonsmall cell lung cancer cells to P-selectin.
Gao Y; Wei M; Zheng S; Ba X; Hao S; Zeng X
J Cancer Res Clin Oncol; 2006 Apr; 132(4):257-64. PubMed ID: 16331491
[TBL] [Abstract][Full Text] [Related]
4. Antimetastatic activities of modified heparins: selectin inhibition by heparin attenuates metastasis.
Borsig L
Semin Thromb Hemost; 2007 Jul; 33(5):540-6. PubMed ID: 17629852
[TBL] [Abstract][Full Text] [Related]
5. Modified heparins inhibit integrin alpha(IIb)beta(3) mediated adhesion of melanoma cells to platelets in vitro and in vivo.
Zhang C; Liu Y; Gao Y; Shen J; Zheng S; Wei M; Zeng X
Int J Cancer; 2009 Nov; 125(9):2058-65. PubMed ID: 19598263
[TBL] [Abstract][Full Text] [Related]
6. Study on anti-metastasis of heparin derivatives as ligand antagonist of p-selectin.
Li Y; Luo JY; Cui HF; Zheng L; Du SS
Biomed Pharmacother; 2010 Dec; 64(10):654-8. PubMed ID: 20970300
[TBL] [Abstract][Full Text] [Related]
7. Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.
Koenig A; Norgard-Sumnicht K; Linhardt R; Varki A
J Clin Invest; 1998 Feb; 101(4):877-89. PubMed ID: 9466983
[TBL] [Abstract][Full Text] [Related]
8. Selectin ligand expression regulates the initial vascular interactions of colon carcinoma cells: the roles of CD44v and alternative sialofucosylated selectin ligands.
Napier SL; Healy ZR; Schnaar RL; Konstantopoulos K
J Biol Chem; 2007 Feb; 282(6):3433-41. PubMed ID: 17135256
[TBL] [Abstract][Full Text] [Related]
9. Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions.
McCarty OJ; Mousa SA; Bray PF; Konstantopoulos K
Blood; 2000 Sep; 96(5):1789-97. PubMed ID: 10961878
[TBL] [Abstract][Full Text] [Related]
10. Tunicate Heparan Sulfate Enriched in 2-Sulfated β-Glucuronic Acid: Structure, Anticoagulant Activity, and Inhibitory Effect on the Binding of Human Colon Adenocarcinoma Cells to Immobilized P-Selectin.
Abreu WS; Soares PAG; Motta JM; Kozlowski EO; Teixeira FCOB; Soares MA; Borsig L; Mourão PAS; Pavão MSG
Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31212795
[TBL] [Abstract][Full Text] [Related]
11. The dual role of CD44 as a functional P-selectin ligand and fibrin receptor in colon carcinoma cell adhesion.
Alves CS; Burdick MM; Thomas SN; Pawar P; Konstantopoulos K
Am J Physiol Cell Physiol; 2008 Apr; 294(4):C907-16. PubMed ID: 18234849
[TBL] [Abstract][Full Text] [Related]
12. Heparan sulfate-like proteoglycans mediate adhesion of human malignant melanoma A375 cells to P-selectin under flow.
Ma YQ; Geng JG
J Immunol; 2000 Jul; 165(1):558-65. PubMed ID: 10861096
[TBL] [Abstract][Full Text] [Related]
13. Affinity and kinetics of P-selectin binding to heparin.
Wang JG; Geng JG
Thromb Haemost; 2003 Aug; 90(2):309-16. PubMed ID: 12888879
[TBL] [Abstract][Full Text] [Related]
14. Selectively desulfated heparin inhibits P-selectin-mediated adhesion of human melanoma cells.
Wei M; Gao Y; Tian M; Li N; Hao S; Zeng X
Cancer Lett; 2005 Nov; 229(1):123-6. PubMed ID: 16157224
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of chemically modified heparin on the P-selectin-mediated adhesion of breast cancer cells in vitro.
Mi D; Gao Y; Zheng S; Ba X; Zeng X
Mol Med Rep; 2009; 2(2):301-6. PubMed ID: 21475829
[TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of heparin and glucan sulfates binding to P-selectin and its impact on the general understanding of selectin inhibition.
Simonis D; Fritzsche J; Alban S; Bendas G
Biochemistry; 2007 May; 46(20):6156-64. PubMed ID: 17458940
[TBL] [Abstract][Full Text] [Related]
17. Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects.
Stevenson JL; Varki A; Borsig L
Thromb Res; 2007; 120 Suppl 2():S107-11. PubMed ID: 18023703
[TBL] [Abstract][Full Text] [Related]
18. Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins.
Wang L; Brown JR; Varki A; Esko JD
J Clin Invest; 2002 Jul; 110(1):127-36. PubMed ID: 12093896
[TBL] [Abstract][Full Text] [Related]
19. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis.
Borsig L; Wong R; Feramisco J; Nadeau DR; Varki NM; Varki A
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3352-7. PubMed ID: 11248082
[TBL] [Abstract][Full Text] [Related]
20. Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets.
Bachelet L; Bertholon I; Lavigne D; Vassy R; Jandrot-Perrus M; Chaubet F; Letourneur D
Biochim Biophys Acta; 2009 Feb; 1790(2):141-6. PubMed ID: 19026722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
